Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

634
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
634
Cardiac Catheterization III: Left Heart Catheterization01:24

Cardiac Catheterization III: Left Heart Catheterization

1.1K
Left heart catheterization is an invasive diagnostic procedure used to evaluate the function and structure of the left side of the heart. It is generally performed to diagnose and treat cardiovascular conditions such as valve abnormalities, coronary artery disease, and congenital heart defects.Diagnostic and therapeutic purposesLeft heart catheterization serves various diagnostic and therapeutic purposes, including:Assessing coronary artery bypass grafts.Evaluating coronary artery disease in...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same authorSame journal

Twenty-Year Follow-up After Combined Heart and Kidney Transplant: A Case Report.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2026
Same author

Cardioplegia strategy in isolated CABG: a comparative evaluation of del Nido, microplegia and St. Thomas II.

General thoracic and cardiovascular surgery·2026
Same author

Valve-sparing aortic root replacement in acute type A aortic dissection.

Cardiovascular journal of Africa·2026
Same author

Assessing the Safety and Efficacy of Non-vitamin K Antagonist Oral Anticoagulants in Solid-Organ Transplant Recipients: A Comprehensive Analysis of a Transplant Center.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2025
Same author

Left Ventricular Assist Device Use as a Bridge to Heart Transplantation in Restrictive Cardiomyopathy: A Series of 2 Cases.

Journal of chest surgery·2025
Same author

Persistence of HLA-DQ Antibodies in Transplant Patients Following Desensitization Treatment.

Experimental and clinical transplantation : official journal of the Middle East Society for Organ Transplantation·2025

Related Experiment Video

Updated: Mar 29, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.3K

Left Ventricular Assist Device Results: Single Center Experience.

Bahadir Gultekin1, Ozgur Ersoy, Murat Ozkan

  • 1From the Department of Cardiovascular Surgery, Baskent University Faculty of Medicine, Ankara, Turkey 06490.

Experimental and Clinical Transplantation : Official Journal of the Middle East Society for Organ Transplantation
|December 8, 2015
PubMed
Summary

Left ventricular assist devices (LVADs) are increasingly used for end-stage heart failure due to limited heart donations. This study shows LVADs as a viable option for patients awaiting transplant, despite a 33.3% mortality rate.

More Related Videos

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

141

Related Experiment Videos

Last Updated: Mar 29, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
07:39

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock

Published on: August 16, 2021

4.3K
Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device
07:41

Insertion, Maintenance, and Removal of the Percutaneous Dual Lumen Cannula Right Ventricular Assist Device

Published on: July 20, 2022

2.5K
Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure
05:18

Implantation of Left Ventricular Assist Device (LVAD) in Juvenile Landrace Swine: A LVAD Implantation Model of Pediatric Heart Failure

Published on: January 16, 2026

141

Area of Science:

  • Cardiology
  • Medical Devices
  • Transplantation

Background:

  • Increasing prevalence of end-stage heart failure and limited donor hearts necessitate alternative treatments.
  • Left ventricular assist devices (LVADs) are emerging as a crucial option for managing advanced cardiac conditions.

Purpose of the Study:

  • To evaluate the outcomes of patients receiving HeartWare LVAD implants at Baskent University Ankara Hospital.
  • To assess the efficacy and complications of LVADs as destination therapy and bridge to transplant.

Main Methods:

  • Retrospective analysis of 24 patients implanted with HeartWare LVADs between April 2012 and February 2015.
  • Data collected included patient demographics, etiology of heart failure, LVAD support type, and adverse events.

Main Results:

  • The study included 24 patients with heart failure due to ischemic (45%) or dilated cardiomyopathy (50%).
  • 10 patients (41.6%) received LVADs for destination therapy, and 14 (48.6%) for bridge to transplant.
  • The mortality rate was 33.3% (8 patients), with 3 patients receiving heart transplants and 1 recovering.

Conclusions:

  • LVADs represent a critical therapeutic option for end-stage heart failure patients awaiting transplantation.
  • Given donor organ scarcity, LVADs offer a life-sustaining solution, improving outcomes for eligible candidates.